© 2016 Algae Health Sciences - A BGG company 

18301 Von Karman Avenue, Suite 910

Irvine, CA 92612
Tel: 949-748-7346
Fax: 925-262-4305

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Please note that the physiological activity of the ingredients described herein is supported by the referenced research and clinical trial reports. Marketers of finished products containing the ingredients described herein are responsible for determining whether the claims made for such products are lawful and in compliance with the laws of the country in which they will market the products.

Press Releases

Two Recent Human Clinical Trials Establish Algae Health Science’s AstaZine® as the Astaxanthin Category Leader for Brain Health

 

IRVINE, CA, USA, November 14, 2019 – Algae Health Sciences, a division of BGG, announced the peer-reviewed publication of two double-blind, placebo-controlled human clinical trials using AstaZine® on brain health. 

 

In the first study (done in USA), significant improvements in three critical markers including feelings of depression, mental fatigue and overall mood state [psychological well-being] were found after 8 weeks in healthy subjects aged 26 to 63 years (median age = 42) taking AstaZine® (Talbott, 2019).  In addition, trends toward improvement in other important mental health parameters such as tension, anger and mental confusion were found through AstaZine® supplementation.

 

The second study (done in Japan) looked at very different yet crucial aspects of brain health.  The subjects in this study were healthy adults who were experiencing mild forgetfulness.  After twelve weeks taking AstaZine®, the treatment group showed a statistically significant improvement versus placebo on two tests for cognitive function and memory.  Both verbal and composite memory significantly improved as tested by Cognitrax (a computerized testing system used to monitor and measure brain performance).  In addition, subjective assessment of symptoms such as remembering people’s names and the names of things were judged by the AstaZine® group as having significantly improved (Sekikawa, 2019). 

 

These two studies are particularly significant because they establish AstaZine® as the leading Astaxanthin product for brain health, a quickly growing category in the supplement industry.

 

“We’re extremely pleased to have two additional successful clinical trials for AstaZine® under our belt,” remarked Yanmei Li, PhD, Chief Scientific Officer of BGG.  “Our goal is to maintain a leadership role in the botanical sector through innovation and continuing scientific discoveries.” 

 

References:  Talbott, S., Hantla, D., Capelli, B., Ding, L., Li, Y., Artaria, C.  “Astaxanthin Supplementation Reduces Depression and Fatigue in Healthy Subjects.”  EC Nutrition 14.3 (2019): 239-246.  Sekikawa, T., Kizawa, Y., Li, Y., Takara., T.  “Cognitive Function Improvement with Astaxanthin Intake:  A Randomized, Double-Blind, Placebo-Controlled Study.”  Pharmacometrics 97 (1/2) 1-13 (2019). 

__________

 

About Algae Health Sciences, Inc:  Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest producer by 2022. The company has facilities in USA, Switzerland, Japan and China.

 

Further Information on Algae Health Sciences:  www.algaehealthsciences.com

__________

 

About BGG:  BGG is a global B2B supplier of ingredients sourced from nature that improve consumer wellness. Building on 25 years of innovative leadership, BGG provides consumer product makers with efficacious ingredients of outstanding quality. This is achieved by specialized sourcing, cultivation and production in the best global regions. BGG’s extensive portfolio originates from algae, fruits and plants. BGG employs a staff of approximately 400, has 6 production sites, international branches in North America, Japan, China and Switzerland and manages sales in over 100 countries. BGG is ISO9001, ISO22000 and GMP certified.

 

Further Information on BGG: www.bggworld.com

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

 

 
 

BGG Announces Astaxanthin Water Dispersible Emulsion for Drink Applications using its new Dispersa® technology platform

 

Irvine, CA, USA, Oct 8 2018 BGG and its affiliates Solix Algredients (Solix) and Algae Health Sciences (AlgaeHealth) announced today that their flagship product, AstaZine® Natural Astaxanthin, has been released in a perfectly water-dispersible emulsion form for use in drink applications. This product features a new technological platform trademarked as Dispersa® that will be used for other BGG products in the future. This innovative technology resolves two key complications common in competitive “water-dispersible” Astaxanthin products: Ineffective dispersion in water applications and residual staining of consumers’ mouths and packaging containers. “We’ve seen competitive products claiming to be water-dispersible which have sedimentation and suspended particles after mixing,” said Lixin Ding, PhD, General Manager of BGG North America. “Astaxanthin using Dispersa® technology is completely transparent and stable over time with no aggregation, sedimentation or suspension of Astaxanthin.”    

 

This product was developed in Switzerland under the direction of BGG Europe’s CEO Christian Artaria who decided to begin with Astaxanthin due to a lack of performance in this category. “We’re extremely enthusiastic about this state-of-the-art development,” said Mr. Artaria. “Astaxanthin is an ideal ingredient for several different applications that lend themselves to a drinkable delivery method, such as sports drinks and anti-aging health shots. Now we can offer a truly suitable solution for pioneering brands to bring the benefits of Astaxanthin to their consumers in drinkable form.” 

____

 

About BGG Group:

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae secondary metabolites and natural vitamins for use in the dietary supplement, food & beverage, cosmetics and pharmaceutical industries.  BGG recently merged with Solix Algredients of Fort Collins, CO, USA to enhance their position in the field of algae-based ingredients.  BGG employs a staff of approximately 400, has 5 production sites, international branches in North America, Japan, China and Switzerland and manages sales in more over 100 countries. BGG is ISO9001, ISO22000 and GMP certified.  Further Information on BGG: www.bggworld.com

_____

 

About Solix Algredients, Inc.:

Solix Algredients, Inc. (Solix) is a B2B supplier of algae-based natural ingredients that benefit health-conscious consumers. Since 2006, the USA-based company has been a recognized leader in algal cultivation and has demonstrated its technology at scale. Solix applies its algae supply chain experience and expertise to market Solasta® Astaxanthin, Solmega® DHA Omega-3 and other natural algal ingredients. Solix Algredients is headquartered in Fort Collins, Colorado. For more information please visit www.solixalgredients.com

_____

 

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in 2020.  The company has facilities in USA, Switzerland, Japan and China.

ural.org

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

HRI Labs |   John Fagan    |    CEO & Co-Founder   |    John.Fagan@hrilabs.org    

Organic & Natural Health Association   |    Karen Howard   |   President & CEO  |  khoward@organicandnatural.org

 

 

 

 

AlgaeHealth Announces AstaZine® Natural Astaxanthin Tested Glyphosate-Free to less than 50 Parts Per Trillion

Irvine, California, April 5, 2018   —  Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today that its flagship product AstaZine® Natural Astaxanthin tested 100% Glyphosate-Free to a level of detection ranging from less than 26 to 50 parts per trillion in independent laboratory testing.  Glyphosate is an herbicide trademarked as RoundUp® which is commonly used in conventional agriculture.  The test was conducted through the Organic & Natural Health Association (O&N) at HRI Labs with equipment specially designed to test to infinitesimal levels of detection.  O&N chose HRI Labs because other labs generally can only test to 20 parts per billion.  “We’re very happy to have tested non-detected to this extreme level of detection,” said Lixin Ding, PhD, Chief Operating Officer for AlgaeHealth.  “And we’re proud to be part of O&N, an organization that is championing the fight for a pure supply chain for the supplement industry.” 

 

Glyphosate is becoming ubiquitous in many countries as farmers increasingly choose to grow genetically modified crops which are designed to be used in conjunction with this herbicide.  Even some organically-grown crops test positive due to drifting of pesticides, use of manures from contaminated cattle, and organic farming in soil that was treated with RoundUp  in the past.  Unfortunately, levels in the low parts per trillion have shown potential health effects in rodents.  “A study in rats showed that Glyphosate levels as low as 50 parts per trillion resulted in liver and kidney damage and indications of fatty liver disease” (Mesnage et al., 2015) said John Fagan, PhD, Co-Founder and CEO of HRI Labs.  “I am concerned that the rapidly increasing incidence of fatty liver disease in Americans may be due to the widespread use of Glyphosate.  In addition, levels of Glyphosate may be an indicator for risk of other contaminants.  We encourage all food and supplement manufacturers to have their products tested to the parts per trillion level to ensure that their supply chain is clean and to avoid potential consumer health issues.” 

 

AlgaeHealth will be displaying with parent company BGG at VitaFoods in Geneva, Switzerland in May 2018. 

_____

AlgaeHealth produces AstaZine in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  AlgaeHealth produces AstaZine® in a variety of forms including Certified Organic Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; and 2.5% microencapsulated beadlets.    

_____

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest producer in 2020. The company has facilities in USA, Switzerland, Japan and China.

Further Information on Algae Health Sciences:  www.algaehealthsciences.com

Further Information on HRI Labs:  http://hrilabs.org

Further Information on the Organic & Natural Health Association:  http://organicandnatural.org

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

HRI Labs |   John Fagan    |    CEO & Co-Founder   |    John.Fagan@hrilabs.org    

Organic & Natural Health Association   |    Karen Howard   |   President & CEO  |  khoward@organicandnatural.org

 

 

AlgaeHealth Announces Publication of a Comprehensive Book on Astaxanthin

Irvine, California, February 14, 2018   —  Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today the publication of a category-leading book on Astaxanthin titled “Natural Astaxanthin:  The Supplement You Can Feel.”  This book is a comprehensive guide to “All Things Astaxanthin” including: 

 

  • Excerpts from several renowned doctors, researchers and opinion leaders describing Astaxanthin in their own words including Dr. Joseph Mercola, Mike Adams “The Health Ranger,” Dr. William Sears, Suzy Cohen “America’s Most Trusted Pharmacist” and more.

  • What makes Natural Astaxanthin “The Supplement You Can Feel” – how 80% of consumers can feel it working in their bodies.

  • Extensive review of the ten clinically-validated health benefits of Natural Astaxanthin.

  • Why nutrition experts are beginning to call Natural Astaxanthin “The Ultimate Anti-Aging Nutrient” and “The Athlete’s Secret Weapon.” 

  • Dosage, bioavailability, safety and other vital information.

  • Differences between sources of Astaxanthin.
     

“This is the third book by Bob Capelli on Astaxanthin and by far his best,” said Joe Huff, CEO of AlgaeHealth North America.  “At over 300 pages, it’s the definitive guide on Astaxanthin for use as a health supplement by humans as well as animals.  This book is a great tool for scientists and physicians as well as people working in the supplement industry, yet is written in an easy-to-read format to be enjoyed by anyone seeking good health.” 

The book will be featured at Expo West at AlgaeHealth’s booth # 3102.  A free digital version is immediately available by e-mailing info@algaehealthsciences.com 

 

_____

AlgaeHealth produces AstaZine in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  AlgaeHealth produces AstaZine® in a variety of forms including Certified Organic Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; and 2.5% microencapsulated beadlets.    

 

_____

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest producer in 2020. The company has facilities in USA, Switzerland, Japan and China.

Further information:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=GSRShc9-tsI

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

NOW Foods and AlgaeHealth Announce NOW’s Launch of Astaxanthin Derived from Organic Microalgae

Bloomingdale, IL, November 30, 2017  —  Natural products manufacturer NOW® (nowfoods.com) and Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today NOW’s launch of Astaxanthin capsules containing AstaZine® Natural Astaxanthin derived from Organic Haematococcus pluvialis microalgae. The product is being launched in a 4mg dose with 90 capsules per bottle.  The two-piece hardshell capsules feature Capsugel’s V-caps®, which are organic compliant, certified vegan, Non-GMO Project Verified, Halal and Kosher.  Astaxanthin acts as a free radical scavenger, supports healthy immune function and healthy aging.*

 

“We’re pleased to be one of the first brands to feature AlgaeHealth’s AstaZine® Astaxanthin because it is derived from Organic algae and  fits so well with our commitment to products that are both supported by research and delivered as nature intended,” said Jim Ritcheske, NOW’s product marketing manager.  “This Astaxanthin is a whole-food nutrient source from spray-dried algae powder that is suitable for vegans. The algae has been certified organic by leading European organic certifier EcoCert.”

“It’s a great honor for AlgaeHealth to have the NOW brand distribute our AstaZine® Astaxanthin,” said Bob Capelli, EVP Global Marketing for AlgaeHealth.  “I’ve watched with incredible admiration during my 27 years in the supplement industry as NOW has grown to become a true leader in the Natural Channel.  Their demonstrated commitment to quality and efficacious nutrients has earned the trust of consumers in the USA and around the world.”  

*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

___________


About NOW:


Founded by Elwood Richard in 1968 on the belief that natural is better, NOW Foods has grown from a small family operation into one of the most highly respected manufacturers in the natural products industry. Still a family-owned company today, NOW provides customers with a comprehensive approach to wellness by offering more than 1,400 natural dietary supplements, foods, sports nutrition and personal care products. NOW is committed to offering safe, affordable products of the highest quality, and is a highly regarded advocate in the natural products industry. Its state-of-the-art manufacturing facility in Bloomingdale, Ill., has been GMP (Good Manufacturing Practices)-certified since 2000 and its in-house laboratory capabilities are among the best in the industry. The company has over 1,500 employees, and its products are sold in more than 60 countries. After nearly 50 years in the natural products industry, NOW remains committed to its original mission – to provide value in products and services that empower people to lead healthier lives. www.NOWFoods.com


About Algae Health Sciences, Inc.:


Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest Astaxanthin producer in 2018. The company has facilities in USA, Switzerland, Japan and China. 

Further information:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=GSRShc9-tsI

 

Press Contacts:

NOW  |   Suzanne Shelton    |     suzanne@sheltongrouppr.com 

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

AlgaeHealth Announces AstaZine® Natural Astaxanthin is now Non-GMO Project Verified

Irvine, California, November 2, 2017  — Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today that its flagship AstaZine® Natural Astaxanthin supercritical CO2 oleoresin extracts produced in Germany and whole-food based Astaxanthin-rich algae powder have attained Non-GMO Project Verified status.  In conjunction with becoming the world’s first Organically Certified Haematococcus pluvialis microalgae product in March 2016 and bearing the NAXA Verified Seal, AstaZine® has now become the clear choice for brands concerned with having the highest-quality third-party audited Astaxanthin raw materials in their finished products.  “The Non-GMO Project Verification seal is known and trusted in the US market and around the world,” said Joe Huff, CEO of AlgaeHealth’s North American operations.  “We’re happy to now offer this additional third-party certification to brands incorporating our AstaZine®.”   

 

AlgaeHealth’s AstaZine® continues an industry-leading trajectory of regulatory and quality achievements over the last two years.  Among the most impressive are:

 

  • The first Astaxanthin NDI notification with the US FDA over 12mg per day (at 24mg per day).  

  • The first company to gain two Novel Food Approvals in the EU for different Astaxanthin extraction methods.

  • Submission of 239 Structure/Function claims for Astaxanthin to FDA without objection.

  • And of course, the world’s first Organically Certified Haematococcus pluvialis product. 

 

____________

AlgaeHealth produces AstaZine in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  AlgaeHealth produces AstaZine® in a variety of forms including Organically Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; and 2.5% microencapsulated beadlets.   

____________

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest Astaxanthin producer in 2020. The company has facilities in USA, Switzerland, Japan and China

 

Further information:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=GSRShc9-tsI

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

AlgaeHealth Announces Positive Clinical Study on Reduction of Heart Rate During Exercise and
Self-Affirmed GRAS for AstaZine® Natural Astaxanthin

Irvine, California, June 15, 2017 — Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today a positive clinical trial publication at the American College of Sports Nutrition for AstaZine® Natural Astaxanthin.  Results showed a reduction in heart rate by 10% during long distance running (Talbott, et al, 2017*).  “We found a very novel effect of natural astaxanthin to improve overall cardiovascular function,” said Shawn Talbott, PhD, the lead researcher.  “The subjects in this study were able to perform the same amount of ‘work’—but at lower cardiovascular ‘strain’ after supplementing with astaxanthin.”  BGG’s CEO, Yanmei Li, PhD added, “The implications of this study for athletes as well as potential benefits for anyone concerned with cardiovascular health are immense.  We plan to publish this result in conjunction with some other exciting clinical results in a strong peer-reviewed journal later this year.”     

 

In addition, the AstaZine® Natural Astaxanthin product line has attained self-affirmed GRAS status (Generally Recognized As Safe).  This accomplishment comes after a quick series of regulatory achievements in regions as diverse as USA, Europe and Australia.  “We are extremely pleased to attain this important milestone to enable more extensive use of AstaZine® in the US food and beverage markets,” said Peinan Zhang, Director of Quality and Regulatory for AlgaeHealth’s parent company BGG.  

 

AlgaeHealth’s Chief Operating Officer Lixin Ding, PhD added, “We are excited to add GRAS status to our list of recent positive developments including: 

 

  • The first Astaxanthin NDI over 12mg per day accepted by the US FDA (at 24mg per day).

  • The first company to gain two Novel Food Approvals in the EU for different Astaxanthin extraction methods.

  • Submission of 239 Structure/Function claims for Astaxanthin to FDA without objection.

  • The first Organic Certified Haematococcus pluvialis microalgae powder.”

* Reference:  Talbott, J., Hantla, D., Talbott, S.  (2017).  “Effect of Astaxanthin Supplementation on  Cardiorespiratory Function in Runners.”  Journal of American College of Sports Medicine Vol. 49, No. 5, S705, June 2, 2017.

 

AlgaeHealth will be represented by its parent company BGG at the upcoming trade show CPhI Shanghai, June 20 – 22, in Shanghai (E4D22) and IFT June 25 – 28 in Las Vegas. 

 

____________

AlgaeHealth produces AstaZine in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  AlgaeHealth produces AstaZine® in a variety of forms including Organic Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; and 2.5% microencapsulated beadlets.   

____________

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing of efficacious ingredients from natural algae sources.  With the second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences plans to become the world’s largest Astaxanthin producer in 2020. The company has facilities in USA, Switzerland, Japan and China

 

Further information:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=GSRShc9-tsI

 

Press Contacts:

 

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

The Future of Algae Farming Interview by NutraIngredients

Palexpo, Geneva, Switzerland, May 9-11, 2017 —  AlgaeHealth’s EVP of Global Marketing Bob Capelli interviewed by NutraIngredients about the future of algae farming.

Watch Interview Here

 

Natural Health Expert Michael Murray, ND Releases New E-book on Natural Astaxanthin and Education Campaign with the Natural Algae Astaxanthin Association

 

Salt Lake City, UT, January 25, 2017 — Today, natural health expert Michael Murray, N.D., launched his new e-book The Whole Body Benefits of Natural Astaxanthin. This new e-book includes information on natural astaxanthin derived from Haematococcus pluvialis microalgae. Dr. Murray is also working with NAXA to promote astaxanthin benefits worldwide.

 

“Astaxanthin is the crowned king of antioxidants,” said Dr. Murray. “It is given this title because of its unique benefits and actions in promoting health and protecting against cellular damage, especially in the brain and vascular system and I’m excited to help educate the public about its unique benefits.”

 

Natural astaxanthin is able to cross the blood-brain and blood-retinal barrier to protect both the brain and eyes and has hundreds of clinical and experimental studies showing astaxanthin benefits the following areas:

 

  • Joint & Tendon Health: Supporting healthy inflammation response is just the foundation of astaxanthin’s athlete-friendly benefits.

  • Skin Health: Reduces fine lines and wrinkles, improves skin elasticity, protects against sun damage, and prevents age spots and hyperpigmentation.

  • Eye Health: Protects against eye fatigue, helps improve visual acuity and depth perception, and increases blood flow to eye tissues.

  • Brain Health: Helps protect against aging and helps improve mental function.

  • Cardiovascular Health: Protects vascular lining, promotes improved blood flow, and protects LDL cholesterol from becoming oxidized (damaged).

 

“Dr. Murray is one of the most renowned natural products experts and is very passionate about natural astaxanthin,” said Scott Steinford, president, Natural Algae Astaxanthin Association. “We are fortunate to have an expert of his caliber helping educate the public on natural astaxanthin’s many health benefits.”

 

The Whole Body Benefits of Natural Astaxanthin e-book is available for free download at Astaxanthin.org.

 

About NAXA 
NAXA is a 501c(6) nonprofit trade association of the world's highest quality manufacturers, growers and marketers of natural algae astaxanthin, derived from Haematococcus pluvialis. NAXA is dedicated to educating the public and dietary supplement industry about the health benefits of Natural Astaxanthin and the major differences between sources. Learn more at www.Astaxanthin.org.

 

BGG Announces an Additional Novel Food Approval for AstaZine®

 

Irvine, CA, USA, January 11, 2017 – BGG and its subsidiary Algae Health Sciences (AlgaeHealth) announced today that their flagship product, AstaZine® Natural Astaxanthin, has won an additional Novel Food approval from the Food Safety Authority of Ireland.  This new regulatory achievement is for BGG’s “Made-in-Europe” supercritically extracted Haematococcus pluvialis Flotow oleoresin products. 

 

“We are extremely happy to offer Astaxanthin in two different grades including our premium supercritical CO2, solvent-free extraction line as well as our ethanol-extracted line, both now with full regulatory approval in the EU,” said Christian Artaria, CEO of BGG’s European operations and CMO for the BGG Group.  “This is yet another regulatory accomplishment in a quickly escalating list that includes innovations such as the first NDI for Astaxanthin greater than 12mg per day dosage.”   

 

BGG is now the first company to have European Novel Food approval for both supercritical and ethanol extracts.

 

“Our goal is to give our customers a variety of options, innovative opportunities, and worldwide marketing reach including the most important regulated markets in our sector such as the USA, Europe, Japan and Australia,” said Bob Capelli, Algae Health Sciences Executive Vice President Global Marketing.

  

About BGG Group:

 

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae secondary metabolites, natural vitamins, natural sweeteners and flavor enhancers for use in the dietary supplement, food & beverage, cosmetics and pharmaceutical industries. BGG employs a staff of approximately 400, has 5 production sites, international branches in North America, Japan, China and Switzerland and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified.

Further Information on BGG: www.bggworld.com

 

 

About Algae Health Sciences, Inc.:

 

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in 2020.  The company has facilities in USA, Switzerland, Japan and China.

 

Further information:  www.algaehealthsciences.com

 

Further Information about Astaxanthin: https://www.youtube.com/watch?v=GSRShc9-tsI    

 

Press Contacts:

 

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

 

BGG Announces New Name for Algae Subsidiary and Website Launch

Irvine, California, August 11, 2016 – BGG announced today a new name for its algae subsidiary along with a new, comprehensive website.  The subsidiary will be called Algae Health Sciences, Inc. moving forward which will be shortened to AlgaeHealth in its logo and for trade relations.  AlgaeHealth’s marketing tagline will be “Improving Health with Algae.”  The new website can be found at www.algaehealthsciences.com

 

“We found ourselves in a trademark dispute with another company with a different but similar name and chose to change our name rather than litigate,” said Joe Huff, CEO of AlgaeHealth’s North American operation.  “To be honest, this worked out fine as we prefer the AlgaeHealth name.  It reflects our company’s mission very well: To research, produce and market efficacious ingredients with unsurpassed quality from algae to improve health.”   

 

The new website has some excellent features related to AlgaeHealth’s flagship product AstaZine® Natural Astaxanthin including:

 

  • A 600+ page list of abstracts on Astaxanthin separated into health benefit categories

  • An infographic summary of the above research

  • An extensive medical research library on Astaxanthin

  • A list of over 200 Structure / Function claims for AstaZine® that have been submitted to the US FDA without objection

 

“We have the world’s first organically certified Astaxanthin crop and the world’s second largest production capacity for Natural Astaxanthin along with unsurpassed product quality, and we want to have a state-of-the-art website to match,” added Mr. Huff. 

 

AlgaeHealth produces AstaZine® in a variety of forms including Organic Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets. 

About Algae Health Sciences, Inc.:

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in late 2020.  The company has facilities in USA, Switzerland, Japan and China.

Further information:  www.algaehealthsciences.com

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

 

About BGG Group:

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae, natural vitamins, natural sweeteners and flavor enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400, has 5 production sites, international branches in USA, Switzerland, Japan and China and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified.

Further Information on BGG:  www.bggworld.com

Press Contact:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

 

 

 

Algae Health Sciences Announces It Now Has 239 Structure/Function Claims Submitted to US FDA Without Objection

 

Irvine, California, May 5, 2016 – Algae Health Sciences, Inc., a subsidiary of BGG, announced today that it now has 239 Structure/Function claims which have been submitted without objection to the US FDA for Natural Astaxanthin.  AlgaeHealth produces the world’s first Certified Organic Astaxanthin product with its Organic Certified Haematococcus pluvialis microalgae powder.  AstaZine® is produced in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  “We’ve been working for months to attain this ground-breaking achievement which now makes us the leader in this critical marketing category,” said Bob Capelli, EVP of Global Marketing for Algae Health Sciences.  “We have some extremely compelling claims that can now be used for products containing our Natural Astaxanthin product, AstaZine®.  This will enable brands to successfully market Astaxanthin with an incredible variety of health claims.  Individual brands can customize their message to consumers while educating about Astaxanthin’s extensive clinically validated health benefits.”      

 

Chief Operating Officer Lixin Ding, PhD added, “Astaxanthin has been validated in approximately 500 different medical research studies to positively affect eye & brain health, improve skin appearance and quality, support joints & tendons, promote cardiovascular health, and provide various benefits for athletes & active people.  And now with 239 Structure/Function claims for labels and marketing literature, brands will easily and legally be able to tell US consumers just how beneficial Astaxanthin really is.” 

 

AlgaeHealth produces AstaZine® in a variety of forms including Organic Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets.

__________________

 

About Algae Health Sciences, Inc.

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in late 2020.  The company has facilities in USA, Switzerland, Japan and China.

 

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

 

About BGG Group

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae, natural vitamins, natural sweeteners and flavor enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400, has 5 production sites, international branches in USA, Switzerland, Japan and China and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified.

Further Information on BGG: www.bggworld.com

 

Press Contact:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

 

 

 

AlgaeHealth Announces Successful NDI Petition with US FDA for AstaZine® Natural Astaxanthin

 

Irvine California, April 6, 2016 – Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today that it has successfully petitioned the US FDA with a New Dietary Ingredients notification (NDI) for its flagship product AstaZine® Natural Astaxanthin. 

 

“We are happy to have received a letter of acknowledgement without objection from FDA for our flagship product, AstaZine® Natural Astaxanthin, which is derived from microalgae that we carefully cultivate in fully closed glass tube photobioreactors (PBRs) free from contamination,” said Joe Huff, CEO of AlgaeHealth’s US-based operation.  “Although we are not the first company to receive an NDI notification for Natural Astaxanthin, this NDI reinforces our commitment to provide the supplement industry with high quality ingredients that you can trust.” 

 

AlgaeHealth produces AstaZine® in a variety of forms including Organic Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets. 

 

__________________

 

About Algae Health Sciences, Inc.

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in late 2020.  The company has facilities in USA, Switzerland, Japan and China.

 

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

 

About BGG Group

Founded in 1995, BGG specializes in the development and manufacture of fruit and botanical extracts, microalgae, natural vitamins, natural sweeteners and flavor enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400, has 5 production sites, international branches in USA, Switzerland, Japan and China and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified.
 

Further Information on BGG: www.bggworld.com

 

Press Contact:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

 

 

 

AlgaeHealth Announces the World’s First Organic Astaxanthin crop

 

Anaheim, March 8th, 2016 – Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, announced today that its Haematococcus pluvialis crop has obtained organic certification by Ecocert, an organic certifying agency based in France. Haematococcus pluvialis is well known for its high content of the strong antioxidant Astaxanthin and is the starting material AlgaeHealth uses for the production of its AstaZine® product line. This landmark achievement comes after a long-term product development project and heavy investment to become the world’s first organically produced Astaxanthin crop.  “AlgaeHealth and our parent company BGG pride ourselves on product quality and innovation” said Joe Huff, CEO of AlgaeHealth’s North American operation.  “This pinnacle achievement for our flagship product AstaZine® Natural Astaxanthin will be very exciting for cutting edge companies that target the organic market.”

 

Christian Artaria, global CMO of BGG and CEO of BGG’s European operation based in Switzerland echoed Mr. Huff’s sentiment.  “The organic market is growing quickly in Europe and North America.  The organic certification of our Haematococcus pluvialis crop differentiates our Astaxanthin from anyone in the market place and answers an unmet need of our customers and end-users.” 

 

Organic labeling laws vary from country to country, but in many regulatory environments brands featuring AstaZine® Natural Astaxanthin 5% Haematococcus pluvialis powder will be able to claim “Astaxanthin from Organic Haematococcus pluvialis” on their labels.  “While brands will have to check on their local regulations, we’re confident that in most markets, our customers can now launch our Astaxanthin powder informing their end-user that the product they are getting is made starting from organic material,” said Mr. Huff.  “We’re currently looking at emerging delivery methods which will allow brands to use a Certified Organic logo such as the USDA’s on their packaging as well.”

 

__________________

 

AlgaeHealth will be displaying at their first industry trade show, Natural Products Expo West/Engredea in Anaheim, California March 10 – 13 at booth #468.

 

For more information, please contact us at info@algaehealthsciences.com

 

About Algae Health Sciences, Inc.

Algae Health Sciences, Inc. focuses on the production and marketing of efficacious ingredients from natural algae sources. With the world’s second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences, Inc., plans to become the world’s largest Astaxanthin producer in 2020. The company has offices in USA, Switzerland, Japan and China.

 

Further Information about Astaxanthin https://youtu.be/GSRShc9-tsI

 

About BGG Group

Founded in 1995, BGG is specialized in development and manufacture of fruit and botanical extracts, microalgae secondary metabolites, natural vitamins, natural sweeteners and flavour enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400 staff, has 5 production sites, international branches in North America, Japan and Switzerland and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified:

 

Further Information on BGG www.bggworld.com

 

ECOCERT is an inspection and certification body, established in France in 1991 by agronomists aware of the need to develop environmentally friendly agriculture and of the importance of offering some form of recognition to those committed to this method of production. From its creation, ECOCERT is specialized in the certification of organic agricultural products. ECOCERT contributed to the expansion of organic farming in the 1990s by helping to draw up French and European regulations. Still very involved in promoting organic farming, ECOCERT today works with French and International institutions in supporting project development. By winning the confidence of professionals and consumers, ECOCERT has become a benchmark in organic certification worldwide. Since the outset, ECOCERT has been an independent company that has remained faithful to its convictions. Consistent with its commitment to organic farming, ECOCERT has opted to put its technical expertise to use in supporting the environment, developing its own specifications for the inspection and certification of products, systems and services. By defining strict requirements that meet consumer expectations, Ecocert Group encourages economic stakeholders to adopt responsible practices 

 

Further Information on ECOCERT: www.ecocert.com

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

 

“Algae Health Sciences” (a BGG Subsidiary) Created to Focus on Nutritional Ingredients from Algae

 

March 3rd, 2016 – BGG is a worldwide leader in Astaxanthin production and technology, with the world’s second largest capacity to produce Natural Astaxanthin from microalgae and products unsurpassed in purity, potency and overall quality.  And with plans in place to become the world’s largest producer in 2020, BGG has quickly become a force in the growing market for Astaxanthin. 

 

The leadership of BGG believes that nutraceutical ingredients from algae will rapidly develop into a large and thriving segment of the supplement industry.  With this belief in mind, BGG has decided to spin off its Astaxanthin farm into a subsidiary in which BGG will remain the major shareholder that will have its sole focus on the production and marketing of efficacious ingredients from natural algae sources.  The company will be named “Algae Health Sciences, Inc.” but will go to market simply as “AlgaeHealth.”  The company will have facilities in USA, Switzerland, Japan and China.  While it will be a separate corporate entity, AlgaeHealth will continue to utilize BGG’s quality facilities and scientists as well as its worldwide Sales Team. 

 

“Our goal is to provide the absolute highest quality algae-based ingredients at favorable pricing,” said industry veteran Joe Huff, CEO of AlgaeHealth’s US-based operation.  “We plan to introduce new products on a consistent basis in the coming years, but for now we’re extremely excited about the prospects for our flagship product Astaxanthin.  And we’re thrilled to have the worldwide reputation for quality ingredients that BGG has gained over the last twenty years backing us.”  

 

In addition to Mr. Huff who has served in a variety of roles in the supplement industry including Sales, Purchasing and Quality, AlgaeHealth has also employed Bob Capelli as its Executive Vice President of Global Marketing.  Mr. Capelli has spent the last 14 years researching, publicizing and marketing Astaxanthin.  He has been published extensively including the world’s first book on Astaxanthin, peer-reviewed papers, magazine articles as well as appearing on countless radio and TV shows around the world as an expert on Astaxanthin.  “I’m honored to be part of this new company and to work closely with a person with a deep knowledge of our industry like Joe Huff.  We’re going to make a great team to get the word out about Astaxanthin’s incredible health benefits and increase consumer awareness.  Our primary objective is to bring the whole Astaxanthin industry to new levels of success and make ‘Astaxanthin’ a household word in the coming years.” 

AlgaeHealth will be displaying at their first industry trade show, Natural Products Expo West/Engredea in Anaheim, California March 10 – 13 at booth #468.  For more information, please contact us at info@algaehealthsciences.com

 

__________________

 

About BGG Group

Founded in 1995, BGG is specialized in development and manufacture of fruit and botanical extracts, microalgae secondary metabolites, natural vitamins, natural sweeteners and flavour enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400 staff, has 5 production sites, international branches in North America, Japan and Switzerland and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified. www.bggworld.com

 

About Algae Health Sciences, Inc.

Algae Health Sciences, Inc. focuses on the production and marketing of efficacious ingredients from natural algae sources. With the world’s second largest capacity to produce Natural Astaxanthin from microalgae, Algae Health Sciences, Inc., plans to become the world’s largest Astaxanthin producer in 2020. The company has offices in USA, Switzerland, Japan and China.

Further Information about Astaxanthin https://www.youtube.com/watch?v=KB-zd81TRus

 

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com

 

AlgaeHealth Announces Industry’s First NDI for Astaxanthin Greater than 12mg per Day Dosage

 

Irvine, California, November 16, 2016 –  Algae Health Sciences, Inc., (AlgaeHealth) a subsidiary of BGG, announced today that it has submitted a new NDI to the US FDA for its flagship product AstaZine® Natural Astaxanthin.  This new NDI builds on a previous NDI in late 2015 for the use of AstaZine® as a bulk dietary ingredient at a dose that does not exceed 12mg of Astaxanthin per day; the new NDI has been filed at a dose that does not exceed 24mg of Astaxanthin per day for a period of thirty days. 

 

The new 24mg per day dosage is the first in the Astaxanthin industry over 12mg per day.  “Based on published studies we generally recommend a dosage of 4mg – 12mg per day over longer periods; however, we are aware that a growing number of people are voluntarily dosing at well over the 12mg upper dosage range,” said Lixin Ding, PhD, Chief Operating Officer of AlgaeHealth.  “In particular, many athletes report that they get better results in the 24mg per day dosage range.”  Published clinical research on Natural Astaxanthin has seen a wide range of dosages.  For example, research on immune health shows excellent results at 2mg per day, while there have been studies done at levels above 12mg showing benefits in a few different areas.  In particular, the human studies on Astaxanthin’s benefits for cardiovascular health have shown positive results above 12mg per day.     

 

 “While we would have preferred not to have the thirty day stipulation, we’re nevertheless happy to have something new to offer in the US market,” said Joe Huff, CEO of AlgaeHealth’s North American operation.  “We’re always thinking of ways to innovate and wanted to give the market a new option regarding dosage.  In particular we see two excellent recommendations for a 24mg dosage during a defined thirty day period:

  • A loading phase for the first thirty days of use for a new Astaxanthin consumer to allow the Astaxanthin to concentrate throughout the body

  • For athletes during the month leading up to an important event”

AstaZine® is produced in a 100% glass tube photobioreactor (PBR) closed system on the world’s second largest Natural Astaxanthin farm.  AlgaeHealth produces AstaZine® in a variety of forms including Organic Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets.

__________________

About Algae Health Sciences, Inc.

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in late 2020.  The company has facilities in USA, Switzerland, Japan and China.

 

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

 

 

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

 

 

AstaZine® receives novel food approval

 

November 24, 2016 – BGG and its subsidiary Algae Health Sciences (AlgaeHealth) announced today that their flagship product, AstaZine® Natural Astaxanthin, has won Novel Food approval from the Food Safety Authority of Ireland.

 

The new approval will allow BGG to market its AstaZine® line throughout Europe. This important achievement builds on two previous successful petitions for AstaZine® with the US FDA:  The first at a dose that does not exceed 12mg of Astaxanthin per day, and the second at a dose that does not exceed 24mg of Astaxanthin per day for a period of thirty days. Following the substantial equivalence opinion released by the Food Safety Authority of Ireland, AstaZine® will be placed on the EU market as an ingredient in food supplements at the current levels of usage. 

 

Commenting on the news, Christian Artaria, CEO of BGG Europe and CMO of BGG group, said: “We are extremely pleased to receive this approval that allows us to market AstaZine® throughout all EU countries.  We are also extremely happy with our regulatory submission track record in EU and US with our fourth successful notification on AstaZine®.  This is not only a sign of the quality of BGG products, but also a sign of the excellent service that we provide to our customers including our regulatory support.”

 

BGG’s AlgaeHealth subsidiary produces AstaZine® in a variety of forms including Organic Certified Haematococcus pluvialis microalgae powder; 5%, 10% and 20% oleoresin; 2% water soluble powder; 2.0% and 2.5% microencapsulated beadlets.   

 ​__________________

About BGG Group:

Founded in 1995, BGG is specialized in development and manufacture of fruit and botanical extracts, microalgae secondary metabolites, natural vitamins, natural sweeteners and flavour enhancers for use in the dietary supplement, food/beverage, cosmetics and pharmaceutical industries. BGG employs about 400 staff, has 5 production sites, international branches in North America, Japan, China and Switzerland and manages sales in more than 20 countries. BGG is ISO9001, ISO22000 and GMP certified

Further Information on BGG: www.bggworld.com

 

About Algae Health Sciences, Inc.

Algae Health Sciences, Inc. (AlgaeHealth), a subsidiary of BGG, focuses on research, production and marketing of efficacious ingredients from natural algae sources. AlgaeHealth is the first company worldwide to receive Organic Certification for its Astaxanthin algae source, and AlgaeHealth’s flagship product, AstaZine® is the world’s purest Natural Astaxanthin.  With the second largest production capacity for Natural Astaxanthin from microalgae, AlgaeHealth plans to become the world’s largest producer in late 2020.  The company has facilities in USA, Switzerland, Japan and China.

 

Further Information about Astaxanthin: https://www.youtube.com/watch?v=KB-zd81TRus

Press Contacts:

AlgaeHealth  |   Bob Capelli    |    Executive Vice President Global Marketing   |    bob@algaehealthsciences.com   |   808.345.7711 (USA)

BGG   |   Christian Artaria   |   Global Chief Marketing Officer   |   christian.artaria@bggworld.com